Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 20/20 | 0.54 |
| ▸ | CA1 | P00915 | 19/20 | 0.54 |
| ▸ | MMP1 | P03956 | 5/20 | 0.54 |
| ▸ | MMP2 | P08253 | 5/20 | 0.54 |
| ▸ | MMP9 | P14780 | 5/20 | 0.54 |
| ▸ | MMP8 | P22894 | 5/20 | 0.54 |
| ▸ | MMP13 | P45452 | 5/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3435260 | 0.95 | CA2 (0.62) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2231136 | 0.95 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2511858 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2230869 | 0.92 | CA2 (0.48) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2516323 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2230420 | 0.92 | CA2 (0.48) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3433952 | 0.92 | CA2 (0.48) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2512376 | 0.92 | CA2 (0.60) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2232021 | 0.92 | CA2 (0.48) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL899196 | 0.92 | CA2 (0.65) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12374720-B2 | Process for preparing a solid electrolyte based on polycarbonates and a composite electrode comprising such a solid electrolyte | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2025-07-29 | — | — | US | claimed |
| EP-4106068-B1 | METHOD FOR PREPARING A SOLID ELECTROLYTE MADE OF POLYCARBONATES AND A COMPOSITE ELECTRODE COMPRISING SUCH A SOLID ELECTROLYTE | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2024-04-24 | — | — | EP | claimed |
| US-20220416298-A1 | PROCESS FOR PREPARING A SOLID ELECTROLYTE BASED ON POLYCARBONATES AND A COMPOSITE ELECTRODE COMPRISING SUCH A SOLID ELECTROLYTE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2022-12-29 | — | — | US | claimed |
| EP-4106068-A1 | METHOD FOR PREPARING A SOLID ELECTROLYTE MADE OF POLYCARBONATES AND A COMPOSITE ELECTRODE COMPRISING SUCH A SOLID ELECTROLYTE | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2022-12-21 | — | — | EP | claimed |
| EP-2834251-B1 | IONIC COMPOUNDS HAVING A SILYLOXY GROUP | HYDRO QUEBEC (CA) | 2019-11-13 | — | — | EP | claimed |
| US-9969757-B2 | Ionic compounds having a silyloxy group | HYDRO-QUEBEC (CA) | 2018-05-15 | — | — | US | claimed |
| US-20150093655-A1 | IONIC COMPOUNDS HAVING A SILYLOXY GROUP | HYDRO-QUEBEC (CA) | 2015-04-02 | — | — | US | claimed |
| EP-2834251-A1 | IONIC COMPOUNDS HAVING A SILYLOXY GROUP | Hydro-Québec (CA) | 2015-02-11 | — | — | EP | claimed |
| WO-2013149349-A1 | IONIC COMPOUNDS HAVING A SILYLOXY GROUP | HYDRO-QUéBEC (CA) | 2013-10-10 | — | — | WO | claimed |
| US-12374720-B2 | Process for preparing a solid electrolyte based on polycarbonates and a composite electrode comprising such a solid electrolyte | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2025-07-29 | — | — | US | disclosed |
| EP-3472671-B1 | A RINSE COMPOSITION, A METHOD FOR FORMING RESIST PATTERNS AND A METHOD FOR MAKING SEMICONDUCTOR DEVICES | MERCK PATENT GMBH (DE) | 2024-06-26 | — | — | EP | disclosed |
| EP-4106068-B1 | METHOD FOR PREPARING A SOLID ELECTROLYTE MADE OF POLYCARBONATES AND A COMPOSITE ELECTRODE COMPRISING SUCH A SOLID ELECTROLYTE | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2024-04-24 | — | — | EP | disclosed |
| CN-112930352-B | Silylamine compounds and latent curing agents containing the same | 广荣化学株式会社 | 2024-02-13 | — | — | CN | disclosed |
| EP-4239747-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | Samsung SDI Co., Ltd. (KR) | 2023-09-06 | — | — | EP | disclosed |
| US-20070298352-A1 | NOVEL SULFONATE SALTS AND DERIVATIVES, PHOTOACID GENERATORS, RESIST COMPOSITIONS, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
| US-20070292808-A1 | Developing Solution Composition for Lithography and Method for Resist Pattern Formation | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1804124-A1 | DEVELOPING SOLUTION COMPOSITION FOR LITHOGRAPHY AND METHOD FOR RESIST PATTERN FORMATION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-07-04 | — | — | EP | disclosed |
| EP-1752827-A1 | RINSING FLUID FOR LITHOGRAPHY | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-02-14 | — | — | EP | disclosed |
| US-20010044534-A1 | Pyrimidine derivative salt | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-11-22 | — | — | US | disclosed |
| US-20010031875-A1 | Optically active ionic liquid | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150093655-A1 | IONIC COMPOUNDS HAVING A SILYLOXY GROUP | EPCAM, ILK, VIM | CA2 105/4885CA1 99/4885MMP1 1486/4885 |
| US-20070298352-A1 | NOVEL SULFONATE SALTS AND DERIVATIVES, PHOTOACID GENERATORS, RESIST COMPOSITIONS, AND PATTERNING PROCESS | HCN3, ASIC3, TST | CA2 29/4885CA1 557/4885MMP1 4795/4885 |
| US-20010031875-A1 | Optically active ionic liquid | IK, INF2, ICMT | CA2 218/4885CA1 1040/4885MMP1 2398/4885 |
| US-20010044534-A1 | Pyrimidine derivative salt | TYMS, RTF2, UMPS | CA2 2702/4885CA1 3747/4885MMP1 4410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.